Ginger Yrabedra
Primary Care · Cartersville, GANPI 1407417652
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,307 and has fallen 53.4% since, to $608 in 2025.
Across 200 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$795
- AbbVie$725
- Lilly USA, LLC$339
- Amgen$302
- AstraZeneca$201
- Axsome Therapeutics, Inc.$147
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $795 |
| AbbVie | 39 | $725 |
| Lilly USA, LLC | 20 | $339 |
| Amgen | 15 | $302 |
| AstraZeneca | 13 | $201 |
| Axsome Therapeutics, Inc. | 2 | $147 |
| Ardelyx, Inc. | 1 | $115 |
| Merck | 8 | $114 |
| Bayer | 6 | $108 |
| GSK | 5 | $88 |
| Astellas Pharma US Inc | 5 | $81 |
| Boehringer Ingelheim | 4 | $75 |
| Biohaven Pharmaceuticals, Inc. | 4 | $69 |
| Novartis | 3 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Dexcom, Inc. | 3 | $61 |
| Amneal Pharmaceuticals LLC | 3 | $58 |
| Exact Sciences | 3 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $56 |
| Kowa Pharmaceuticals America, Inc. | 3 | $56 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Corcept Therapeutics | 2 | $47 |
| Pfizer | 3 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Saluda Medical Americas, Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,927 in reported general payments places this provider in the 85th percentile of 235 primary care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 16 | $14,761 |
| PremarinEstrogens, Conjugated | 11 | $2,145 |
| SynthroidLevothyroxine Sodium | 12 | $655 |
| Losartan Potassium | 47 | $429 |
| Rosuvastatin Calcium | 17 | $353 |
| Levothyroxine Sodium | 35 | $303 |
| Bupropion Hcl | 17 | $269 |
| Sertraline Hcl | 17 | $199 |
| Atorvastatin Calcium | 32 | $169 |
| Glipizide | 11 | $159 |
| Amlodipine Besylate | 35 | $104 |
| Pantoprazole Sodium | 21 | $101 |
| Metformin Hcl | 19 | $56 |
| Meloxicam | 11 | $34 |
| Prednisone | 16 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $795 | $14,76116 claims |
| PfizerPremarin | $40 | $2,14511 claims |
| AbbVieSynthroid | $725 | $65512 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $58 | $30335 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 235 primary care providers in Georgia.
Other primary care in Cartersville
- Clare GomezCartersville$2K
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.